Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1410

Similar articles for PubMed (Select 18670358)

1.

Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.

Lane Z, Hansel DE, Epstein JI.

Am J Surg Pathol. 2008 Sep;32(9):1322-6. doi: 10.1097/PAS.0b013e3181656ca0.

PMID:
18670358
2.

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.

Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.

Am J Surg Pathol. 2007 Aug;31(8):1246-55.

PMID:
17667550
3.

The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.

Sheridan T, Herawi M, Epstein JI, Illei PB.

Am J Surg Pathol. 2007 Sep;31(9):1351-5.

PMID:
17721190
4.

Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.

Osunkoya AO, Epstein JI.

Am J Surg Pathol. 2007 Sep;31(9):1323-9.

PMID:
17721186
5.

Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.

Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE.

Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.

PMID:
21572312
6.

Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.

Leite KR, Mitteldorf CA, Srougi M, Dall'oglio MF, Antunes AA, Pontes J Jr, Camara-Lopes LH.

Ann Diagn Pathol. 2008 Aug;12(4):260-6. doi: 10.1016/j.anndiagpath.2007.11.001. Epub 2008 Apr 18.

PMID:
18620992
8.
9.

Immunohistochemistry in diagnostic surgical pathology of the prostate.

Hameed O, Humphrey PA.

Semin Diagn Pathol. 2005 Feb;22(1):88-104. Review.

PMID:
16512601
11.

Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.

Wang W, Epstein JI.

Am J Surg Pathol. 2008 Jan;32(1):65-71.

PMID:
18162772
12.

Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.

Samplaski MK, Heston W, Elson P, Magi-Galluzzi C, Hansel DE.

Mod Pathol. 2011 Nov;24(11):1521-9. doi: 10.1038/modpathol.2011.112. Epub 2011 Jul 1. Erratum in: Mod Pathol. 2011 Nov;24(11):1531.

13.

Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.

Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J.

Hum Pathol. 1998 Dec;29(12):1451-6.

PMID:
9865832
14.

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB.

Cancer Res. 1999 Jul 1;59(13):3192-8.

15.

Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.

Epstein JI, Kuhajda FP, Lieberman PH.

Hum Pathol. 1986 Sep;17(9):939-42.

PMID:
2428729
16.

Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.

McCluggage WG, Shah R, Connolly LE, McBride HA.

Int J Gynecol Pathol. 2008 Jan;27(1):92-100.

PMID:
18156982
17.

Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.

Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ.

Am J Surg Pathol. 2001 Nov;25(11):1380-7.

PMID:
11684954
18.

Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.

Martínez-Rodríguez M, Ramos D, Soriano P, Subramaniam M, Navarro S, Llombart-Bosch A.

Int J Surg Pathol. 2007 Apr;15(2):213-8.

PMID:
17478786
19.

Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.

Seibel JL, Prasad S, Weiss RE, Bancila E, Epstein JI.

Hum Pathol. 2002 Feb;33(2):236-41.

PMID:
11957151
20.

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.

Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA.

Am J Clin Pathol. 2000 Mar;113(3):383-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk